Skip to content
Review Open access

Functional Dyspepsia in Clinical Practice Current Recommendations and Future Perspectives

Sep 2026 · Quality in Sport · 0 citations · 29 references

TL;DR

The evolving understanding of FD supports a shift from empirical symptom-based treatment toward individualized, mechanism-informed care, and emerging approaches targeting the duodenal microenvironment, epithelial barrier, gut microbiota, and gut–brain axis are promising.

Abstract

Background:Functional dyspepsia (FD) is a common disorder of gut–brain interaction and a major cause of chronic upper gastrointestinal symptoms and impaired quality of life. Current evidence challenges the traditional view of FD as solely a gastric motility disorder and indicates a multifactorial pathophysiology involving motor dysfunction, visceral hypersensitivity, duodenal immune activation, epithelial barrier impairment, gut microbiota alterations, and dysregulated gut–brain communication. Aim:To review current knowledge of the pathophysiology, clinical presentation, diagnosis, and evidence-based management of FD, with emphasis on emerging therapeutic targets and precision medicine. Material and methods:A narrative review was conducted using international clinical guidelines, systematic reviews, meta-analyses, randomized controlled trials, and translational studies concerning FD diagnosis, treatment, and recent advances in disease mechanisms. Results:FD is a heterogeneous disorder in which several overlapping biological mechanisms contribute to symptom generation. Diagnosis is primarily based on the Rome IV criteria after exclusion of structural disease. Established management includes lifestyle modification, Helicobacter pylori eradication, proton pump inhibitors, prokinetics, neuromodulators, and psychological therapies. Emerging approaches targeting the duodenal microenvironment, epithelial barrier, gut microbiota, and gut–brain axis are promising. Nevertheless, treatment efficacy remains modest because of biological heterogeneity and the lack of validated biomarkers for patient stratification. Conclusions:The evolving understanding of FD supports a shift from empirical symptom-based treatment toward individualized, mechanism-informed care. Future research should focus on clinically applicable biomarkers, improved phenotyping, and high-quality clinical trials to enable precision medicine and improve long-term outcomes.

Read PDF

Similar papers

Review Open access Sep 2026

Features of pharmacological and dietary management of functional dyspepsia in children. Review

Objective — to analyze current scientific data on the etiological and pathogenetic mechanisms underlying the development of functional dyspepsia in children, as well as the characteristics of its pharmacological and dietary management.

V. Bobrova, Y. Proshchenko · 0 citations
Review Open access Sep 2026

The Role of Diet in Functional Dyspepsia

Functional dyspepsia (FD) is a disorder of gut–brain interaction affecting approximately 7% of the global population under Rome IV criteria, characterised by postprandial fullness, early satiation, epigastric pain, and/or epigastric burning in the absence of identifiable organic disease. Meal ingestion is the dominant...

Luisa Bertin, C. Van de Bruaene, E. Formisano et al. · 0 citations
Review Open access Aug 2026

IRRITABLE BOWEL SYNDROME IN CHILDREN: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT

This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions.

Agata Leszek, Michał Stermach, Z. Lecyk et al. · 0 citations
Review Open access Aug 2026

Inflammation and Its Pathophysiological Role in Functional Dyspepsia

Many individuals worldwide suffer from functional dyspepsia (FD), a chronic digestive disorder characterized by symptoms in the absence of observable structural abnormalities within the gastrointestinal system. This condition significantly impacts the quality of life and healthcare expenditures. Although the precise et...

Christina Permata Shalim, I. Mariadi · 0 citations
Review Open access Sep 2026

Evolving Concepts in the Diagnosis and Management of Fibromyalgia: A Moving Target

A narrative review aims to provide a concise, updated, and clinically relevant overview of the current evidence regarding the pathogenesis, diagnosis, and multidisciplinary management of FM to improve diagnostic accuracy and support individualized patient management.

Hoa Ngan Doan, Jun-Sung Moon, W. Park et al. · 0 citations
Open access Sep 2026

Ayurvedic Management of Functional Dyspepsia: A Case Report Using Rome IV Criteria

Background: Functional Dyspepsia (FD) is a common disorder of gut–brain interaction characterized by persistent upper abdominal symptoms without organic pathology. Conventional therapies often provide incomplete relief. Ayurveda offers multimodal approaches that may benefit FD symptomatology. Case Presentation: A 42-ye...

Sumit Raina, Diksha Raina, Punita Pandey · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.